Thirumalai Chemicals Limited (TCL) has announced the release of its Corporate Presentation for the Quarter and Nine Months ended December 2025. The presentation, which details the company's performance and strategic updates, will be uploaded to the company's website. The company overview highlights its evolution since 1973, with a diversified product portfolio including Phthalic Anhydride, Maleic Anhydride, Malic Acid, Fumaric Acid, and Diethyl Phthalate. TCL operates manufacturing facilities in Ranipet, India, and Dahej, India, as well as a subsidiary in Malaysia. The presentation also details the ongoing expansion with a new facility in the USA (TCL Specialities LLC) set to commence operations, focusing on Malic Acid, Fumaric Acid, and Maleic Anhydride. Key highlights for Q3 FY26 indicate weak global chemical demand, elevated distributor inventory levels, and subdued demand in China's infrastructure and housing sectors. The company reported a consolidated Total Income of ₹420 crore and an EBITDA of -₹11 crore for Q3 FY26, compared to ₹447 crore and -₹20 crore respectively in Q3 FY25. For the nine months ended December 2025 (9M FY26), consolidated Total Income stood at ₹1,322 crore with an EBITDA of -₹31 crore, a significant decrease from ₹1,539 crore and ₹47 crore in 9M FY25. The USA facility's first phase of commercial operations for Maleic Anhydride commenced in December 2025, with commissioning activities for the rest of the facility ongoing and expected to stabilize during H1 CY26. The company is also focusing on ESG initiatives, aiming for a 25% reduction in GHG emissions by 2030 and a 10% reduction in water consumption by 2030, based on a 2022-23 baseline.
